R-CVP Followed by Rituximab Maintenance Therapy for Patients With Advanced Marginal Zone B-cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2016
At a glance
- Drugs Rituximab (Primary)
- Indications B cell lymphoma
- Focus Therapeutic Use
- 08 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2014 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov record.
- 08 Oct 2010 New trial record